ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Mechanisms of LYL1-associated T-ALL development | Baylor College of Medicine / Margaret Goodell, PhD | Innovation Grants | 2012 | Texas |
Center for Pediatric T Cell Therapy (CEPET) | Baylor College of Medicine / Cliona Rooney | Phase I/II Infrastructure Grants | 2010 | Texas |
Immunotherapy Of Neuroblastoma With Natural Killer T Cells Engineered To Target O-acetyl-GD2 | Baylor College of Medicine / Andras Heczey, MD | Young Investigator Grants | 2014 | Texas |
Telomeres and Telomerase in Pediatric Acute Myeloid Leukemia | Baylor College of Medicine / Maria Gramatges | Young Investigator Grants | 2011 | Texas |
DICER1-Driven Cancers: Models, Mechanisms and Therapies | University of Texas Southwestern Medical Center at Dallas / James Amatruda, MD/PhD | Innovation Grants | 2016 | Texas |
Pre-Clinical Testing of T cells Coded with CARs for DIPG | University of Texas / Laurence Cooper, MD, PhD | Innovation Grants | 2013 | Texas |
Immunotherapy for Pediatric Atypical Teratoid/Rhabdoid Tumor | Baylor College of Medicine / William Decker, PhD | Reach Grants | 2013 | Texas |
B-lapachone as a Novel Targeted Therapy for ATRTs and other Pediatric Cancers | University of Texas Southwestern Medical Center / James Amatruda, MD, PhD | Reach Grants | 2013 | Texas |
Parallel sequencing to identify the causes of childhood cancer | Baylor College of Medicine / Sharon Plon | Innovation Grants | 2008 | Texas |
Adoptive immunotherapy using clinical-grade T cells. | University of Texas M.D. Anderson Cancer Center / Laurence Cooper, MD, PhD | Innovation Grants | 2007 | Texas |